Page 41

20Ways Spring 2014 Issue

20WAYS to Improve patIent Care & pharmaCy profItabIlIty Fagron Advanced Derma Inspired by 30 years’ experience of pharmaceutical compounding for dermatology and with expert knowledge in dermatology, Fagron successfully created a revolutionary concept for advanced, individualized dermatological therapy and care. SPRING 2014 I Ret aIl/CommuNIty • S PeCIalty • ltC 39 General Manager: Marije van Dalen Founded: 1980 Employees: 60+ Toll-free Phone: (800) 423-6967 Fax: (800) 339-1596 Address: 2400 Pilot Knob Road St. Paul, MN 55120 Website: Order online at: fagron.us Company Background Fagron, Inc. provides pharmacists in the United States with high quality products and solutions. Fagron continuously introduces innovative products, based on research done in our own R&D center. We work together with our customers, universities, physicians, and other care providers to provide optimized compounding solutions. We continuously perform studies on our products, dedicated to providing you the best quality possible. Fagron supports customers by offering complimentary professional support. Our staff of experienced pharmacists and technicians provide technical assistance and answers to pharmaceutical & professional technical questions. Fagron, Inc. is part of the Fagron Group, the global market leader in pharmaceutical compounding, and is headquartered in the Netherlands. Fagron is active in 30 countries and employs over 160 pharmacists worldwide. Product Overview Fagron Advanced Derma offers unique benefits based on the latest scientific knowledge in pharmaceutical compounding for dermatology. • Used in formulating individualized treatment based on skin type. • Designed for optimum patient comfort to improve the patient’s quality of life and compliance. • cGMP produced vehicles with high quality ingredients. • Vehicles are tested to be stable and durable with a broad range of APIs and dermaceutical ingredients (DCIs) used in dermatology (compatibility table available on request). • Providing efficient, time-saving compounding solutions. • Worldwide availability without membership commitments. • Based on the latest scientific developments in compounding and dermatology. • Facilitates collaboration between health professionals to maximize therapeutic results. • All vehicles are uniquely formulated to contain only ingredients with maximum skin-tolerance1. • Example formulations available for help with prescribing and compounding. 1 Literature references available. Product Specifications n Fitalite™ Natural Gel Cream Base • Formula with natural emulsifiers and phytosomes. • Excellent moisturizing properties to support skin balance. • Ultra-light, non-greasy skin feel. • Gentle moisturizing properties. n Versatile™ Vanishing O/W Cream Base • Holds up to 50% API. • Pleasant and soft, non-greasy skin feel. • Excellent moisturizing properties to support skin balance. • Rapidly vanishes into the skin. n Versatile™ Rich Enriched O/W Cream Base • For more dry skin, holds up to 40% API. • Sophisticated, protective formula with extra natural lipids. • Soft and caring skin feel with minimal greasiness. • Excellent moisturizing and protective properties protect skin balance and hydration. • Rapidly vanishes into the skin. n Nourivan™ Antiox Antioxidant O/W Cream Base • With natural antioxidants to protect active pharmaceutical ingredients. • Pleasant, soft skin feel. • Excellent moisturizing properties. • Rapidly vanishes into the skin. • Unique compatibility with active pharmaceutical ingredients susceptible to oxidation; adding additional antioxidants usually is not required. n Espumil™ Lipophilic Foam Base • Creamy foam formula with minimal greasiness. • Gentle formula without gaseous propellants. • Light skin feel, drip free. • A base solution for easy compounding. • Generates a foam when dispensed in our foam-activating pump. • Used with lipophilic active pharmaceutical and dermaceutical ingredients. • Contains propylene glycol for enhanced solubility of lipophilic active pharmaceutical ingredients.


20Ways Spring 2014 Issue
To see the actual publication please follow the link above